The slip
PARKINSON RECEIPTno. 4276
20 Oct 2026, 13:53 UTCdopamine neurons, braak
predictionDOCK3 in dopamine neurons tracks Braak Lewy-body stage
registered588fd75b6b4850a3
discovery+0.23 p=0.545 n=9
replication+0.32 p=0.400 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.23, p 0.545)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT67feebbb985d4241e4814b04…
follows 9eb81b2660ef…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4276: DOCK3 in dopamine neurons, braak
- power
- full sample +0.33 (p 0.188, n 18), 95% CI -0.17 to +0.69. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: +0.38 (p 0.120, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.39 (p 0.105, n 18). could be the mix.
- skeptic
- leave-one-out range +0.26 to +0.47, sign flips 0; without severely affected donors +0.33 (p 0.188, n 18). fragile.
- cell type
- strongest in astrocytes: -0.66 (p 0.0031, n 18) vs +0.33 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DOCK3 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up DOCK3 · astrocytes · braak: substantia nigra, an independent cohort (already registered)